Heart Failure With Preserved Ejection Fraction‐Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort
Clinical Cardiology · 2026-07 · 49 (7)
DOI: 10.1002/clc.70402 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Cardiology, online erschienen am 29.06.2026. Verfasst von Erik Thunström und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Coronary Artery Disease, Heart Failure, Sleep Apnea, Obstructive, Stroke Volume. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Heart-Lung Foundation, Agreement concerning research and education of doctors" of Västra Götalandsregionen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Heart failure with preserved ejection fraction (HFpEF) is closely linked to aging and cardiometabolic risk factors and frequently coexists with obstructive sleep apnea (OSA). We aimed to investigate the prevalence and clinical correlates of an HFpEF‐like phenotype in a revascularized coronary artery disease (CAD cohort), focusing on OSA and its severity.
Methods
A total of 435 patients with preserved left ventricular ejection fraction from the RICCADSA cohort were included. OSA was defined as apnea–hypopnea index (AHI) ≥ 15 events/h. HFpEF‐like phenotype was defined by ≥ 2 of the following: elevated filling pressures (E/e′ ≥ 15), left atrial enlargement, increased left ventricular mass index, elevated pulmonary artery systolic pressure (≥ 35 mmHg), and elevated NT‐proBNP (≥ 125 pg/mL). Multivariable logistic regression analyses included age, sex, obesity, hypertension, diabetes, and OSA status. Additional models evaluated AHI and oxygen desaturation index (ODI) as continuous variables and assessed the impact of excluding body mass index (BMI).
Results
Mean age was 63.6 ± 8.6 years and BMI 28.1 ± 4.1 kg/m 2 ; 69.9% met HFpEF‐like criteria. Age and obesity were independently associated with HFpEF‐like phenotype, whereas categorical OSA was not. AHI and ODI were not independently associated after adjustment; however, in models excluding BMI, both AHI (OR 1.019, 95% CI 1.005–1.033) and ODI (OR 1.030, 95% CI 1.010–1.050) were significant predictors.
Conclusions
HFpEF‐like phenotype is highly prevalent in CAD and primarily associated with aging and adiposity. The relationship between OSA severity and cardiac remodeling appears dependent on obesity, underscoring the interplay between cardiometabolic and sleep‐related factors. Pre‐registered Clinical Trial Number The RICCADSA trial is registered at ClinicalTrials.gov (NCT00519597) and in the Swedish national research registry (FoU i Sverige—Research and Development in Sweden; registration no. VGSKAS‐4731; April 29, 2005).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medicine, Geriatrics and Emergency Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
- Department of Internal Medicine, Skaraborg Hospital, Lidköping, Sweden.
- Department of Pulmonary Medicine, School of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Pulmonary Medicine, Koc University School of Medicine, Istanbul, Türkiye.
- Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Erik Thunström, Helena Glantz, Aylin Pihtili, Yüksel Peker
Förderung
- Swedish Research Council
- Swedish Heart-Lung Foundation
- Agreement concerning research and education of doctors" of Västra Götalandsregionen
- Research fund at Skaraborg Hospital
- Skaraborg Research and Development Council
- Vetenskapsrådet
Zitieren
APA
Thunström, E., Glantz, H., Pihtili, A., & Peker, Y. (2026). Heart Failure With Preserved Ejection Fraction‐Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort. Clinical Cardiology, 49(7). https://doi.org/10.1002/clc.70402
Vancouver
Thunström E, Glantz H, Pihtili A, Peker Y. Heart Failure With Preserved Ejection Fraction‐Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort. Clinical Cardiology. 2026;49(7). doi:10.1002/clc.70402
BibTeX
@article{Thunstrm2026,
author = {Thunström, Erik and Glantz, Helena and Pihtili, Aylin and Peker, Yüksel},
title = {Heart Failure With Preserved Ejection Fraction‐Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {7},
doi = {10.1002/clc.70402}
}
EUVIMED